Steven Itzkowitz is a Gastroenterology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 38 publications with 268 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Sponsor: Exact Sciences Corporation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
7 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
85.4%Aminosalicylate35.6%Mesalamine77%Lialda23%Part D<11 patientsProton pump inhibitor25.9%Pantoprazole Sodium55%Omeprazole45%Part D<11 patients+ 2 more classes in this area
Cancer & immunology
9.3%TNF inhibitor4.9%Cimzia100%Part D<11 patientsJAK inhibitor4.5%Rinvoq100%Part D<11 patientsNervous system
5.3%Natural opium alkaloids5.3%Opium Tincture100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 1988–2010 per NIH RePORTER. The latest:
- Trefoil Factors in GI Cancer Biology
Icahn School of Medicine at Mount Sinai
FY2010$271,200R01CA109189 - Trefoil Factors in GI Cancer Biology
Icahn School of Medicine at Mount Sinai
FY2009$271,200R01CA109189 - Trefoil Factors in GI Cancer Biology
Icahn School of Medicine at Mount Sinai
FY2008$271,200R01CA109189
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”